Pectenotoxin-2 represses telomerase activity in human leukemia cells through suppression of hTERT gene expression and Akt-dependent hTERT phosphorylation
Abstract
In this study, we found that pectenotoxin-2 (PTX-2) decreased cell viability and inhibited telomerase activity with downregulation of hTERT expression in human leukemia cells. PTX-2 treatment also reduced c-Myc and Sp1 gene expression and DNA binding activity. Further chromatin immunoprecipitation assay demonstrated that PTX-2 attenuated the binding of c-Myc and Sp1 to the regulatory regions of hTERT. We also observed that PTX-2 treatment attenuated the phosphorylation of Akt, thereby reducing the phosphorylation and nuclear translocation of hTERT. We concluded that PTX-2 suppressed telomerase activity through the transcriptional and post-translational suppression of hTERT and this process precedes cellular differentiation of human leukemia cells.
Structured summary
Abbreviations: PTX-2, pectenotoxin-2, TRAP, telomeric repeat amplification protocol, ELISA, enzyme-linked immunosorbent assay, ChIP, Chromatin immunoprecipitation, PARP, DNA repair enzyme poly-(ADP-ribose) polymerase
Keywords: Pectenotoxin-2, hTERT, c-Myc, Sp1, Akt
To access this article, please choose from the options below
PII: S0014-5793(08)00717-5
doi:10.1016/j.febslet.2008.08.030
© 2008 Federation of European Biochemical Societies. Published by Elsevier BV. All rights reserved.
